July 7, 2020
Eisai rolled out two new products in Japan on July 6, the sleep inducer Dayvigo (lemborexant) and a fine granule formulation of the anti-epileptic drug Fycompa (perampanel). Originated by Eisai, Dayvigo is a competitive antagonist that binds to two subtypes...read more